Advanced Search

 

Study ID Status Title Patient Level Data
111492 Completed XP065: A Phase 1, Single-Dose Study of the Disposition of 14C Radiolabeled XP13512 (GSK1838262) in Healthy Male Volunteers
111495 Completed XP084: Population Pharmacokinetic-Pharmacodynamic Analysis of XP13512 Efficacy and Tolerability Endpoints in Restless Legs Syndrome
111497 Completed A single-blind, randomized, placebo controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK1362885 in healthy normal subjects. Study Listed on ClinicalStudyDataRequest.com
111507 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals' HPV vaccine (580299) co-administrated with a commercially available vaccine in healthy female adolescents Study Listed on ClinicalStudyDataRequest.com
111517 Completed Safety and immunogenicity of a candidate tuberculosis (TB) vaccine (692342) in HIV-positive adults.
111521 Completed A Phase 2a, Multicenter, Randomized, Parallel, Double-Blind, Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK1349572 Monotherapy Versus Placebo Over 10 days in HIV-1 Infected Adults (ING111521)
111524 Completed XP066: A Phase 1, Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of XP13512 (GSK1838262) Sustained Release (SR) Tablets in Patients with Severe Renal Impairment and End Stage Renal Disease (ESRD) Patients on Hemodialysis
111528 Completed A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment with Ropinirole PR as Adjunctive Therapy in Patients with Parkinson’s Disease who are not optimally controlled on L-Dopa
111535 Completed Immunogenicity and reactogenicity study of GlaxoSmithKline Biologicals' Infanrix™/Hib vaccine administered as a booster dose to 18-24 months old children Study Listed on ClinicalStudyDataRequest.com
111539 Completed A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke Study Listed on ClinicalStudyDataRequest.com
111562 Completed Case-control study to evaluate the vaccine effectiveness of Rotarix™ against Rotavirus Severe Gastroenteritis (RV SGE) among hospitalized children born after 6 March 2006 and at least 12 weeks of age, in Belem, Brazil
111567 Completed Evaluation of the immunogenicity and safety of a commercially available vaccine when co-administered with GlaxoSmithKline Biologicals' HPV vaccine (580299) in healthy female subjects. Study Listed on ClinicalStudyDataRequest.com
111569 Completed A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L-dopa in patients with advanced Parkinson’s disease
111580 Completed A single blind, randomized, cross-over study to compare the oral disposition of levocetirizine when given alone (5mg) or as the racemate (cetirizine 10mg), and parallel study to investigate the safety and tolerability and the pharmacokinetics of levocetirizine and cetirizine, following
111582 Completed An Open Label Study to Examine the Effects of Low-Fat and High-Fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients
111587 Completed A healthy volunteer repeat dose study to evaluate; the safety, tolerability, pharmacokinetics, effects on the pharmacokinetics of midazolam and the neurokinin 1 receptor occupancy of GSK1144814
111592 Completed Assessment of the Anti-Inflammatory activity, efficacy and safety of Intravenous SB-681323 in subjects at risk for development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS). Study Listed on ClinicalStudyDataRequest.com
111596 Completed A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Study Listed on ClinicalStudyDataRequest.com
111598 Completed A study in type 2 diabetic subjects of single and multiple doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound Study Listed on ClinicalStudyDataRequest.com
111601 Terminated A randomized, placebo-controlled, single-blind study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of otelixizumab in rheumatoid arthritis subjects Study Listed on ClinicalStudyDataRequest.com
111602 Completed A Phase I, open label, randomized, four-period crossover studyto evaluate the effects of Maalox® Advanced Maximum Strengthand One A Day® Maximum on pharmacokinetics of GSK1349572in healthy adult subjects
111603 Completed A Phase I, open label, two period, single fixed-sequence crossover study to evaluate the effect of etravirine on GSK1349572 pharmacokinetics in healthy adult subjects (ING111603)
111604 Completed A Phase I, Open Label, Single Sequence,Drug Interaction Study Evaluating Plasma GSK1349572 and Tenofovir Pharmacokinetics in Healthy Adult Subjects (ING111604)
111610 Completed A randomized, double-blind, placebo-controlled study in healthy volunteers to examine the safety, tolerability and pharmacokinetics of a) single, ascending and b) twice-daily repeat doses of intranasal SB-705498 Study Listed on ClinicalStudyDataRequest.com
111611 Completed A randomised, double-blind, placebo-controlled study to assess the effect of oral, single dose SB-705498 in a validated intranasal capsaicin challenge model in healthy volunteers Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.